Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Spironolactone reduces hair growth in women with unexplained excessive hairiness.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Zinc supplements and weaning cured a breast-fed baby's zinc deficiency caused by a gene mutation.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Hypertrichosis lanuginosa causes excessive fine hair growth, often linked to genetics or cancer, with limited treatment options.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Fat cells are important for tissue repair and stem cell support in various body parts.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

High doses of norethindrone acetate in rats caused various organ changes but didn't significantly increase tumor rates.